Identification and Functional Validation of Novel Pathogenic Variants in Primary Immunodeficiencies
European Journal of Immunology · 2025
DOI: 10.1002/eji.70057 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Arvinden Vr und 26 weiteren Autor:innen. Beteiligte Einrichtung: CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India. Hauptthemen laut MEDLINE: Primary Immunodeficiency Diseases, Immunologic Deficiency Syndromes. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Primary immunodeficiency diseases (PIDs) are inherited disorders caused by genetic defects affecting immune function, leading to recurrent infections, autoimmunity, and malignancies. Many PIDs remain genetically uncharacterized, largely due to rare variants with unclear pathogenicity, which complicates the process of establishing an accurate diagnosis. Next‐generation sequencing (NGS) technology enables the identification of molecular defects, improving the diagnosis of PIDs. Functional validation of genetic variants identified through PID‐related gene screenings is crucial for determining their clinical significance. In this study, we identified five novel variants in PID‐related genes in six families using whole‐exome sequencing. These variants include FCHO1 (E44K), NCF2 (A206P), NCF2 (c.174 + 1G > A), STAT1 (L199F), and a copy number deletion in LRBA (exon 9–17). Functional validation was performed for four of these variants: STAT1 (L199F) using pSTAT1 assay, NCF2 (A206P and c.174 + 1G > A) by DHR assay, and FCHO1 (E44K) using CRISPR‐mediated genome editing. Overall, the present study expands the knowledge of previously unreported variants in primary immunodeficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Delhi, India.
- Academy of Scientific and Innovative Research (AcSIR), CSIR-HRDC Campus, Ghaziabad, India.
- Department of Pediatrics, FPID Regional Diagnostic Centre, Government Medical College Kozhikode, Kozhikode, India.
- Department of Biological Sciences and Bioengineering and Mehta Family Centre for Engineering in Medicine, Indian Institute of Technology Kanpur, Kanpur, India.
- Vishwanath Cancer Care Foundation, Mumbai, India.
- Department of Pediatric Immunology, ICMR National Institute of Immunohematology, Mumbai, India.
Zitieren
APA
Vr, A., Govindaraj, G. M., Iyer, A. R., Paul, S., Edavazhippurath, A., Jain, A., Gupta, P., Deshmukh, G. Y., Singh, S., Saravanakumar, V., Bhardwaj, J., Sharma, S., Benny, T. P., Saravanan, P., Bhoyar, R. C., Imran, M., Senthivel, V., Divakar, M. K., Vignesh, H., …, & Scaria, V. (2025). Identification and Functional Validation of Novel Pathogenic Variants in Primary Immunodeficiencies. European Journal of Immunology. https://doi.org/10.1002/eji.70057
Vancouver
Vr A, Govindaraj GM, Iyer AR, Paul S, Edavazhippurath A, Jain A, et al. Identification and Functional Validation of Novel Pathogenic Variants in Primary Immunodeficiencies. European Journal of Immunology. 2025. doi:10.1002/eji.70057
BibTeX
@article{Vr2025,
author = {Vr, Arvinden and Govindaraj, Geeta Madathil and Iyer, Aditya Ramdas and Paul, Sangita and Edavazhippurath, Athulya and Jain, Abhinav and Gupta, Pragya and Deshmukh, Gauspasha Yusuf and Singh, Shivani and Saravanakumar, Vinodh and Bhardwaj, Juhi and Sharma, Srishti and Benny, Tancia P and Saravanan, Priya and Bhoyar, Rahul C and Imran, Mohamed and Senthivel, Vigneshwar and Divakar, Mohit Kumar and Vignesh, Harie and Jolly, Bani and Dalvi, Aparna and Bargir, Umair Ahmed and Madkaikar, Manisha and Bk, Binukumar and Sivasubbu, Sridhar and Ramalingam, Sivaprakash and Scaria, Vinod},
title = {Identification and Functional Validation of Novel Pathogenic Variants in Primary Immunodeficiencies},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.70057}
}
EUVIMED